Literature DB >> 12849925

Prevalence of diabetes, impaired fasting glucose and insulin resistance syndrome in an urban Indian population.

Arvind Gupta1, Rajeev Gupta, Mukesh Sarna, Shweta Rastogi, V P Gupta, Kunal Kothari.   

Abstract

OBJECTIVE: Epidemiological study among urban subjects in western India to determine prevalence of diabetes, insulin resistance syndrome (IRS) and their risk factors.
METHODS: Randomly selected adults > or =20 years were studied using stratified sampling. Target sample was 1,800 (men 960, women 840). 1123 subjects (response 62.4%) were evaluated and blood samples were available in 532 men and 559 women (n=1091, 60.6%). Measurement of anthropometric variables, blood pressure, fasting blood glucose and lipids was performed. Atherosclerosis risk factors were determined using current guidelines. Diabetes was diagnosed when the subject was a known diabetic or fasting blood glucose was > or =126 mg/dl, impaired fasting glucose (IFG) diagnosed when fasting glucose was 110-125 mg/dl. IRS was diagnosed when any three of-IFG, high triglycerides >150 mg/dl, low HDL cholesterol (men<40 mg/dl, women<50 mg/dl), central obesity (men>102 cm, women>88 cm), or high normal blood pressure (>130/>85 mmHg) or hypertension-were present.
RESULTS: Diabetes was present in 70 men (13.2%) and 64 women (11.5%). Age-adjusted prevalence of diabetes was 9.3% in men (95% confidence intervals (CI) 6.7-11.8), 8.1% in women (CI 5.8-10.4) and 8.6% overall (CI 6.9-10.3). IFG was in 28 men (5.3%) and 29 women (5.2%). IRS was present in 52 men (9.8%) and 114 women (20.4%) with age-adjusted prevalence of 7.9% in men (CI 6.7-9.1) and 17.5% in women (CI 14.4-20.6) with an overall prevalence of 12.8% (CI 10.8-14.8). Other metabolic abnormalities of IRS in men and women were high triglycerides in 32.1 and 28.6%, low HDL cholesterol in 54.9 and 90.2%; central obesity in 21.8 and 44.0%, and high normal blood pressure or hypertension in 35.5 and 32.4%. IFG subjects had similar atherosclerosis risk factor profile as normal subjects while those with IRS and diabetes had significantly greater prevalence of obesity, central obesity, hypertension, high triglycerides and low HDL (P<0.01).
CONCLUSIONS: There is s significant prevalence of diabetes and IRS in this urban Indian population. Subjects with diabetes as well as IRS have greater prevalence of obesity, central obesity, hypertension, hypertriglyceridemia and low HDL as compared with normal subjects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12849925     DOI: 10.1016/s0168-8227(03)00085-8

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  48 in total

1.  High prevalence of cardiovascular risk factors among policemen in Puducherry, South India.

Authors:  Jayalakshmy Ramakrishnan; Sumanth Mallikarjuna Majgi; Kariyarath Cheriyath Premarajan; Subitha Lakshminarayanan; Susila Thangaraj; Palanivel Chinnakali
Journal:  J Cardiovasc Dis Res       Date:  2013-06-18

Review 2.  Type 2 diabetes in youth in South Asia.

Authors:  P A Praveen; S Ram Kumar; Nikhil Tandon
Journal:  Curr Diab Rep       Date:  2015-02       Impact factor: 4.810

3.  Prevalence of the metabolic syndrome in acute myocardial infarction and its impact on hospital outcomes.

Authors:  S Pandey; N Baral; S Majhi; P Acharya; P Karki; S Shrestha; B K L Das; L Chandra
Journal:  Int J Diabetes Dev Ctries       Date:  2009-04

4.  A study on the prevalence of type 2 diabetes in coastal Karnataka.

Authors:  Chythra R Rao; Veena G Kamath; Avinash Shetty; Asha Kamath
Journal:  Int J Diabetes Dev Ctries       Date:  2010-04

5.  Metabolic syndrome: an occupational perspective.

Authors:  Chitra V Nair
Journal:  Indian J Community Med       Date:  2010-01

6.  Prevalence of metabolic syndrome and associated risk factors among Turkish adults: Trabzon MetS study.

Authors:  Cihangir Erem; Arif Hacihasanoglu; Orhan Deger; Murat Topbaş; Ilgin Hosver; Halil Onder Ersoz; Gamze Can
Journal:  Endocrine       Date:  2008-03-13       Impact factor: 3.633

7.  Prevalence of metabolic syndrome in Galicia (NW Spain) on four alternative definitions and association with insulin resistance.

Authors:  M A Tomé; M A Botana; C Cadarso-Suárez; A Rego-Iraeta; A Fernández-Mariño; J A Mato; I Solache; R Perez-Fernandez
Journal:  J Endocrinol Invest       Date:  2009-03-24       Impact factor: 4.256

Review 8.  Metabolic syndrome in South Asians.

Authors:  C Venkata S Ram; John A Farmer
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-05-31       Impact factor: 3.738

9.  Metabolic syndrome in human immunodeficiency virus positive patients.

Authors:  Sarita Bajaj; Susheel Kumar Tyagi; Anudita Bhargava
Journal:  Indian J Endocrinol Metab       Date:  2013-01

10.  The rs1142345 in TPMT Affects the Therapeutic Effect of Traditional Hypoglycemic Herbs in Prediabetes.

Authors:  Xi Li; Feng-Mei Lian; Dong Guo; Lan Fan; Jie Tang; Jing-Bo Peng; Hong-Wen Deng; Zhao-Qian Liu; Xin-Hua Xiao; Yan-Rong Wang; Ke-Yi Qu; Sheng Deng; Qi Zhong; Yi-Ling Sha; Yan Zhu; Yu-Jing Bai; Xin-Yan Chen; Qiang Zhou; Hong-Hao Zhou; Xiao-Lin Tong; Wei Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-29       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.